Transforming the biotech industry, Cosmo Bio is leveraging partnerships, an extensive product database and cold storage solutions to expand globally. Its vision emphasizes both innovation and market expansion.
Cosmo Bio plays a crucial role in the global biotechnology field. The company provides over 12 million products from 500 suppliers worldwide, which are used by researchers to advance scientific discovery. Cosmo Bio's proprietary database enables researchers to access products more efficiently, suggesting optimal tools and materials for their experiments based on shared information. This system greatly enhances research processes, equipping scientists with the resources they need for cutting-edge work.
While trading remains a cornerstone of its operations, Cosmo Bio has expanded into manufacturing, particularly through its Sapporo-based facility. By producing its own reagents, the company reduces dependence on imports and avoids exposure to currency fluctuations. “By having manufacturing capabilities, we can reduce the risk of currency exchange,” says President Norihiko Shibayama. This dual focus on trading and manufacturing allows Cosmo Bio to stay competitive both domestically and internationally.
The company has also developed advanced logistics systems to ensure the safe transportation of temperature-sensitive reagents. Using air freight and a sophisticated customs clearance process, Cosmo Bio ensures products reach their destinations promptly and in the right conditions. This logistical expertise is a key asset as the company continues to grow its global reach.
Looking ahead, Cosmo Bio plans further expansion into overseas markets, particularly high-tech research hubs in the U.S. and Europe. The company is also rolling out its cutting-edge new Chicken Egg Bioreactor—unique, cost-reducing technology that’s capable of stably producing large quantities of useful recombinant proteins. “We want to expand our network and commercialize this product,” Mr. Shibayama says.
0 COMMENTS